Cite
HARVARD Citation
Peng, Y. et al. (2020). Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients. Cancer biology & therapy. 21 (2), pp. 189-196. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Peng, Y. et al. (2020). Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients. Cancer biology & therapy. 21 (2), pp. 189-196. [Online].